Tuesday, Alaunos Therapeutics Announced A Reversed Stock Split Of 1-for-10, Effective July 18-8K
Portfolio Pulse from Benzinga Newsdesk
Alaunos Therapeutics announced a 1-for-10 reverse stock split, effective July 18.
July 18, 2024 | 9:01 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Alaunos Therapeutics announced a 1-for-10 reverse stock split, effective July 18. This action is typically taken to increase the stock price by reducing the number of shares outstanding.
A reverse stock split is often used to boost the stock price by reducing the number of shares outstanding. This can make the stock more attractive to institutional investors and meet listing requirements, but it does not change the company's market capitalization.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100